Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Alendronic acid Stories

2013-02-01 23:03:40

The Firm is currently investigating Fosamax femur fracture lawsuits on behalf of individuals who suffered atypical femur fractures, allegedly due to Fosamax. New York, New York (PRWEB) February 01, 2013 The federal judge overseeing Fosamax lawsuits in the U.S. District Court for the Southern District of New York has issued a ruling allowing a plaintiff to add an allegation that Fosamax caused her to suffer a femur fracture, Bernstein Liebhard LLP reports. According to court documents, the...

2013-01-26 23:03:08

Bernstein Liebhard LLP is currently evaluating Fosamax lawsuits on behalf of individuals who suffered atypical femur fractures allegedly due to their use of the drug. New York, New York (PRWEB) January 26, 2013 Fosamax lawsuits continue to move forward in the consolidated litigation underway in New Jersey Superior Court, Atlantic County, Bernstein Liebhard LLP reports. According to court records, the next status conference in the New Jersey litigation has been scheduled for February 21,...

2013-01-22 16:26:48

SAN ANTONIO, Texas, Jan. 22, 2013 /PRNewswire/ -- BINOSTO®( )(alendronate sodium) Effervescent Tablet for oral solution 70 mg, was named a "Product to Watch" in the January 7, 2013, edition of BioCentury, the Bernstein Report on BioBusiness newsletter. BioCentury is an internationally recognized leader in providing pharmaceutical analysis and data, along with value-added information for biotechnology and pharmaceutical companies. BINOSTO, a product of Mission Pharmacal and...

2012-12-29 05:00:33

Law firm offers no win - no fee promise for clients injured from the drug Fosamax, used to treat bone-weakening diseases. Fosamax has allegedly been linked to serious side effects, such as femur fractures, osteonecrosis of the jaw injury, esophageal cancer, and severe musculoskeletal pain. (PRWEB) December 28, 2012 Law Firm Offers No Win - No Fee Promise For Clients injured from the drug Fosamax, used to treat bone-weakening diseases. Fosamax has allegedly been linked to serious side...

2012-12-02 05:01:05

Bernstein Liebhard LLP continues to investigate Fosamax lawsuits on behalf of individuals who suffered atypical femur fractures allegedly due to their use of Fosamax. New York, NY (PRWEB) December 01, 2012 As Fosamax lawsuits continue to move forward, a new study has found that patients who take bisphosphonates like Fosamax may be at increased risk for upper gastrointestinal cancer, Bernstein Liebhard LLP reports. The study compared 8,636 men and women who had a recorded incident of upper...

2012-10-26 04:00:10

Estate of Fosamax User Who Developed Osteonecrosis of the Jaw Reaches Confidential “Stipulation Agreement” with Merck on Damages. Melville, NY (PRWEB) October 25, 2012 The Fosamax side effect lawyers at Alonso Krangle LLP, a national law firm focused on fighting for the rights of serious personal injury victims, reports that Merck & Co. has reached a confidential “stipulation agreement” with the estate of a Fosamax user who developed Osteonecrosis of the Jaw...

2012-10-23 07:29:59

FREIENBACH, Switzerland, October 23, 2012 /PRNewswire/ -- EffRx to Regain Rights Outside of North America EffRx Pharmaceuticals SA [http://www.effrx.com ] is proud to announce that BINOSTO(TM) [http://www.binosto.com ](alendronate sodium) Effervescent Tablet for buffered oral solution (70 mg) is now available by prescription in the United States. The U.S. Food and Drug Administration earlier this year approved BINOSTO [http://www.binosto.com ]to treat...

2012-10-15 03:24:10

SANTA BARBARA, Calif., Oct. 15, 2012 /PRNewswire-iReach/ -- Medical researchers report evidence of severe deterioration of bone material properties in patients that sustain an atypical femur fracture after taking bisphosphonates for more than five years. Results of a 70 person clinical study were presented at the 2012 Annual Meeting of the American Society for Bone and Mineral Research (ASBMR) in Minneapolis, Minnesota from October 12-15, 2012. In recent years, a potential link between long...

2012-10-11 11:26:57

SAN ANTONIO, Oct. 11, 2012 /PRNewswire/ -- Mission Pharmacal Company today announced that BINOSTO(TM)( )(alendronate sodium) Effervescent Tablet for buffered oral solution (70 mg) is now available by prescription in the United States. The U.S. Food and Drug Administration has approved BINOSTO to treat osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis. (Photo: http://photos.prnewswire.com/prnh/20121011/PH91455 ) BINOSTO delivers easy-to-swallow...

2012-10-05 10:22:05

Motley Rice Recognized For Success in Plaintiffs' Bar MT. PLEASANT, S.C., Oct. 5, 2012 /PRNewswire-USNewswire/ -- Motley Rice is proud to announce that it is one of 19 firms across the nation selected for The National Law Journal's 2012 Plaintiffs' Hot List. "All of us at Motley Rice are very honored to be nationally recognized. We are fortunate to have the human resources of talented and committed attorneys and staff who work at this high level and believe their work for our clients...